These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 31110111)

  • 1. Declarations of interest by members of Health Canada's special advisory committees and panels: a descriptive study.
    Lexchin J
    CMAJ Open; 2019; 7(2):E334-E340. PubMed ID: 31110111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Revisiting financial conflicts of interest in FDA advisory committees.
    Pham-Kanter G
    Milbank Q; 2014 Sep; 92(3):446-70. PubMed ID: 25199895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Financial conflict of interest disclosure and voting patterns at Food and Drug Administration Drug Advisory Committee meetings.
    Lurie P; Almeida CM; Stine N; Stine AR; Wolfe SM
    JAMA; 2006 Apr; 295(16):1921-8. PubMed ID: 16639051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Conflicts of interest in scientific advisory panels].
    Kullberg BJ; Geleijnse M
    Ned Tijdschr Geneeskd; 2022 Oct; 166():. PubMed ID: 36300497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conflicts of Interest in Clinical Guidelines: Update of U.S. Preventive Services Task Force Policies and Procedures.
    Ngo-Metzger Q; Moyer V; Grossman D; Ebell M; Woo M; Miller T; Brummer T; Chowdhury J; Kato E; Siu A; Phillips W; Davidson K; Phipps M; Bibbins-Domingo K
    Am J Prev Med; 2018 Jan; 54(1S1):S70-S80. PubMed ID: 29254528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Voting behavior during FDA Medical Device Advisory Committee panel meetings.
    Maisel-Campbell A; Schlessinger DI; Yanes AF; Veledar E; Reynolds KA; Ibrahim SA; Kang BY; Anvery N; Poon E; Alam M
    PLoS One; 2022; 17(6):e0267134. PubMed ID: 35749461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Financial Conflicts of Interest at FDA Drug Advisory Committee Meetings.
    Hayes MJ; Prasad V
    Hastings Cent Rep; 2018 Mar; 48(2):10-13. PubMed ID: 29590518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does seating location impact voting behavior on Food and Drug Administration advisory committees?
    Broniatowski DA; Magee CL
    Am J Ther; 2013; 20(5):502-6. PubMed ID: 21642834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome.
    Teede HJ; Misso ML; Costello MF; Dokras A; Laven J; Moran L; Piltonen T; Norman RJ;
    Hum Reprod; 2018 Sep; 33(9):1602-1618. PubMed ID: 30052961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome.
    Teede HJ; Misso ML; Costello MF; Dokras A; Laven J; Moran L; Piltonen T; Norman RJ;
    Fertil Steril; 2018 Aug; 110(3):364-379. PubMed ID: 30033227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncologic Drugs Advisory Committee Recommendations and Approval of Cancer Drugs by the US Food and Drug Administration.
    Tibau A; Ocana A; Anguera G; Seruga B; Templeton AJ; Barnadas A; Amir E
    JAMA Oncol; 2016 Jun; 2(6):744-50. PubMed ID: 26940233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Food and Drug Administration advisory committees and panels: how they are applied to the drug regulatory process.
    Ciociola AA; Karlstadt RG; Pambianco DJ; Woods KL; Ehrenpreis ED;
    Am J Gastroenterol; 2014 Oct; 109(10):1508-12. PubMed ID: 25001252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Requesting conflicts of interest declarations from the European Medicines Agency: 3-year follow-up status.
    Boesen K; Gøtzsche PC; Ioannidis JPA
    Epidemiol Psychiatr Sci; 2024 Mar; 33():e17. PubMed ID: 38529624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Financial interests of patient organisations contributing to technology assessment at England's National Institute for Health and Care Excellence: policy review.
    Mandeville KL; Barker R; Packham A; Sowerby C; Yarrow K; Patrick H
    BMJ; 2019 Jan; 364():k5300. PubMed ID: 30651227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MPs call for removal of Health Canada's breast-implant panel members.
    Eggertson L
    CMAJ; 2005 Nov; 173(10):1144. PubMed ID: 16275959
    [No Abstract]   [Full Text] [Related]  

  • 16. Financial ties between DSM-IV panel members and the pharmaceutical industry.
    Cosgrove L; Krimsky S; Vijayaraghavan M; Schneider L
    Psychother Psychosom; 2006; 75(3):154-60. PubMed ID: 16636630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scientific journals and their authors' financial interests: a pilot study.
    Krimsky S; Rothenberg LS; Stott P; Kyle G
    Psychother Psychosom; 1998; 67(4-5):194-201. PubMed ID: 9693346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the conflicts of interest disclosed by the program reviewers of the scoliosis research society (SRS) congresses, 2010-2014.
    Barrios C; Alfonso J; Lloris JM; Hevia E; Burgos J
    PLoS One; 2018; 13(10):e0204993. PubMed ID: 30307972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Issues in data monitoring and interim analysis of trials.
    Grant AM; Altman DG; Babiker AB; Campbell MK; Clemens FJ; Darbyshire JH; Elbourne DR; McLeer SK; Parmar MK; Pocock SJ; Spiegelhalter DJ; Sydes MR; Walker AE; Wallace SA;
    Health Technol Assess; 2005 Mar; 9(7):1-238, iii-iv. PubMed ID: 15763038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Committee on Natural Toxins and Food Allergens. Marine and freshwater toxins.
    Hungerford JM
    J AOAC Int; 2005; 88(1):299-313. PubMed ID: 15759755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.